Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had with relevant stakeholders to help ensure that people who received doses of the AstraZeneca covid-19 vaccine produced in India are able to demonstrate their vaccination status when travelling overseas.

The Government continues to liaise with international partners and other organisations, such as the International Civil Aviation Organization and the World Health Organization, to support the work on certification to ensure that global travel is unhindered and supported by a common approach.

All doses of AstraZeneca COVID-19 vaccines manufactured in India and administered in the United Kingdom are the same product, under the same authorisation as all other AstraZeneca vaccine doses deployed in the UK, now known commercially Vaxzevria. They appear on the NHS COVID Pass as such, which has been available for international travel since May. Decisions on which vaccines countries will accept at their borders are for respective Governments and we continue to actively engage with these countries to ensure all AstraZeneca doses administered in the UK, including those manufactured in India, are recognised.